The evolving landscape of tropical fever necessitates a dynamic approach to treatment protocols. Current recommendations, often guided by the World Health Organization Global Body, prioritize the use of artemisinin-based combination therapies (ACTs) as first-line management in most endemic regions. However, the rise of artemisinin immunity demands

A new drug is generating optimism in the medical community, as it shows promising results for both weight loss and diabetes management. In ongoing clinical trials, individuals taking the medication experienced noticeable reductions in BMI. Moreover, the drug also demonstrated positive effects in blood sugar control for patients with type 2 diabetes